Plain-English translation of NCT05384769 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a blood test — called a liquid biopsy — can work as an easier, at-home way to screen for lung cancer in people who smoke or used to smoke. Right now, the standard screening test is a CT scan of the chest, which requires a special machine and a trip to a clinic. This study wants to see if a simple blood draw could be a good alternative, and whether people would prefer it.
Lung cancer screening saves lives, but CT scans are expensive, require special equipment, and some people avoid them because of the radiation or inconvenience. A blood test that could be done at home might catch lung cancer earlier while being easier and safer for high-risk smokers.
You likely qualify if…
You likely don't qualify if…
You will choose one of two groups: in the first group, you get a blood test at home, and if the results are positive, you can choose to have a CT scan; in the second group, you get a CT scan and can optionally add a blood test on the same day. Either way, you'll be checked in again 6 months later to see how you're doing and whether you followed through with any additional screening.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States